Watch: Tracking the virus

February 20, 2020
Kenneth Rosenthal, head of the viral vaccines division at the McMaster Immunology Research Centre, talks about how research teams across the globe are searching for a COVID-19 vaccine.
February 20, 2020
Kenneth Rosenthal, head of the viral vaccines division at the McMaster Immunology Research Centre, talks about how research teams across the globe are searching for a COVID-19 vaccine.
All republished articles must be attributed in the following way and contain links to both the site and original article: “This article was first published on Brighter World. Read the original article.”
The Communications and Public Affairs Office is staffed from 8:30 a.m. to 4:30 p.m. Monday to
Friday.
The University has a broadcast quality television studio to facilitate live and pre-recorded interviews with media. Learn more about our experts.
It's been five years since the start of the COVID-19 pandemic. McMaster experts are developing a better vaccine, using AI to power drug discovery, and sharing evidence-based ways to protect the health of communities and the economy.
The AeroVax study will test needle-free vaccines that proved more effective than traditional injected vaccines in pre-clinical studies and the Phase 1 trial.